Literature DB >> 18501638

Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates.

R Sanchez-Pernaute1, J-Q Wang, D Kuruppu, L Cao, W Tueckmantel, A Kozikowski, O Isacson, A-L Brownell.   

Abstract

The interplay between dopamine and glutamate in the basal ganglia regulates critical aspects of motor learning and behavior. Metabotropic glutamate receptors (mGluR) are increasingly regarded as key modulators of neuroadaptation in these circuits, in normal and disease conditions. Using PET, we demonstrate a significant upregulation of mGluR type 5 in the striatum of MPTP-lesioned, parkinsonian primates, providing the basis for therapeutic exploration of mGluR5 antagonists in Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501638      PMCID: PMC2532975          DOI: 10.1016/j.neuroimage.2008.04.170

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  20 in total

1.  Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.

Authors:  Nathalie Breysse; Marianne Amalric; Pascal Salin
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

2.  Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers.

Authors:  Terence G Hamill; Stephen Krause; Christine Ryan; Celine Bonnefous; Steve Govek; T Jon Seiders; Nicholas D P Cosford; Jeffrey Roppe; Ted Kamenecka; Shil Patel; Raymond E Gibson; Sandra Sanabria; Kerry Riffel; Waisi Eng; Christopher King; Xiaoqing Yang; Mitchell D Green; Stacey S O'Malley; Richard Hargreaves; H Donald Burns
Journal:  Synapse       Date:  2005-06-15       Impact factor: 2.562

Review 3.  GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates.

Authors:  Y Smith; A Charara; J E Hanson; M Paquet; A I Levey
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

4.  mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.

Authors:  Pershia Samadi; Laurent Grégoire; Marc Morissette; Fréderic Calon; Abdallah Hadj Tahar; Mehdi Dridi; Nancy Belanger; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
Journal:  Neurobiol Aging       Date:  2007-03-13       Impact factor: 4.673

5.  Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.

Authors:  Anna Liisa Brownell; Kelly Canales; Y Iris Chen; Bruce G Jenkins; Christopher Owen; Elijahu Livni; Meixiang Yu; Francesca Cicchetti; Rosario Sanchez-Pernaute; Ole Isacson
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

6.  Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia.

Authors:  Christine Konradi; Jenny E Westin; Manolo Carta; Molly E Eaton; Katarzyna Kuter; Andrzej Dekundy; Martin Lundblad; M Angela Cenci
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996

7.  Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract.

Authors:  M J Messenger; L G Dawson; S Duty
Journal:  Neuropharmacology       Date:  2002-08       Impact factor: 5.250

8.  Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors.

Authors:  Hui Zhang; David Sulzer
Journal:  J Neurosci       Date:  2003-11-19       Impact factor: 6.167

Review 9.  Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases.

Authors:  Paolo Gubellini; Antonio Pisani; Diego Centonze; Giorgio Bernardi; Paolo Calabresi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

10.  Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.

Authors:  Bruce G Jenkins; Rosario Sanchez-Pernaute; Anna-Liisa Brownell; Yin-Ching Iris Chen; Ole Isacson
Journal:  J Neurosci       Date:  2004-10-27       Impact factor: 6.709

View more
  21 in total

1.  Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats.

Authors:  Anna Jiménez; Merce Bonastre; Esther Aguilar; Concepcio Marin
Journal:  Psychopharmacology (Berl)       Date:  2009-07-28       Impact factor: 4.530

2.  Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2009-08-04       Impact factor: 3.590

Review 3.  GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Res       Date:  2014-11-26       Impact factor: 4.939

4.  Microfluidic continuous-flow radiosynthesis of [18F]FPEB suitable for human PET imaging.

Authors:  Steven H Liang; Daniel L Yokell; Raul N Jackson; Peter A Rice; Ronald Callahan; Keith A Johnson; David Alagille; Gilles Tamagnan; Thomas Lee Collier; Neil Vasdev
Journal:  Medchemcomm       Date:  2014-04-01       Impact factor: 3.597

5.  PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5).

Authors:  Dan Li; Hong Shan; Peter Conti; Zibo Li
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-12-15

6.  PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson's Disease.

Authors:  Wen Yuan Luo; Su Qian Xing; Ping Zhu; Chen Guang Zhang; Hui Min Yang; Nicholas Van Halm-Lutterodt; Li Gu; Hong Zhang
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 7.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

Review 8.  Therapeutic promise and principles: metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

9.  Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.

Authors:  Diana L Price; Edward Rockenstein; Kiren Ubhi; Van Phung; Natalie MacLean-Lewis; David Askay; Anna Cartier; Brian Spencer; Christina Patrick; Paula Desplats; Mark H Ellisman; Eliezer Masliah
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

10.  Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.

Authors:  Tanya Chotibut; Richard W Davis; Jennifer C Arnold; Zachary Frenchek; Shawn Gurwara; Vimala Bondada; James W Geddes; Michael F Salvatore
Journal:  Mol Neurobiol       Date:  2013-12-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.